Association between weight control and recurrence of atrial fibrillation after catheter ablation in overweight and obese patients
10.3760/cma.j.issn.0253-3758.2019.08.002
- VernacularTitle: 体重控制与超重及肥胖患者心房颤动射频消融术后复发的关系
- Author:
Zhaoxu JIA
1
,
2
;
Chao JIANG
;
Shangxin LU
;
Jiapeng LIU
;
Xueyuan GUO
;
Songnan LI
;
Nian LIU
;
Chenxi JIANG
;
Caihua SANG
;
Ribo TANG
;
Deyong LONG
;
Ronghui YU
;
Rong BAI
;
Jiahui WU
;
Xin DU
;
Jianzeng DONG
;
Changsheng MA
Author Information
1. Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University
2. National Clinical Research Center for Cardiovascular Diseases, Beijing 100029, China
- Publication Type:Journal Article
- Keywords:
Atrial fibrillation;
Catheter ablation;
Body weight;
Recurrence
- From:
Chinese Journal of Cardiology
2019;47(8):595-601
- CountryChina
- Language:Chinese
-
Abstract:
Objectives:This study explored the relationship between weight control and atrial fibrillation (AF) recurrence after catheter ablation in overweight and obese patients.
Methods:We prospectively enrolled consecutive 333 overweight and obese patients aged 28 to 87 years old, who underwent catheter ablation for AF in Beijing Anzhen Hospital between October 2015 and February 2016. Data of patients′ characteristics, laboratory examination and treatment were collected at baseline. Each patient was followed up at 3, 6 and 12 months after ablation to collect information on weight, AF recurrence, stroke, major bleeding, hospitalization for cardiovascular reasons and death, etc. Patients were divided into weight controlled group (ΔBMI<-1 kg/m2) and weight uncontrolled group (ΔBMI≥-1 kg/m2), according to the changes in the most recent exposure BMI before AF recurrence in patients with recurrence or the BMI at 12 months′ follow-up in patients without recurrence and the BMI at baseline. Multivariate logistic regression was performed to adjust other known risk factors of AF recurrence and to explore the association between weight control and AF recurrence after catheter ablation.
Results:There were 54 patients in weight controlled group and 279 patients in weight uncontrolled group. There were no significant differences in age, gender, education level, left atrial size and history of hypertension between the two groups (all P>0.05). The proportion of patients using angiotensin-converting enzyme inhibitors/angiotensin receptor blockers was higher in the weight controlled group (50.0%(27/54) vs. 34.8%(97/279), P=0.034). However, there was no significant difference in the proportion of patients with obesity (33.3% (18/54) vs. 29.7% (83/279)), paroxysmal AF (59.3% (32/54) vs. 56.6% (158/279)) and AF duration less than 5 years (76.9% (40/52) vs. 65.4% (178/272)) between the weight controlled group and the uncontrolled group. During 1-year follow-up after ablation, the recurrence rate of AF was significantly lower in the weight controlled group than that in the weight uncontrolled group (14.8% (8/54) vs. 32.6%(91/279), P=0.009). Multivariable logistic regression analysis shows that weight control is independently associated with a lower postoperative AF recurrence rate (OR=0.40, 95%CI 0.18-0.90, P=0.026).
Conclusion:Weight control is strongly associated with a lower AF recurrence rate after catheter ablation in overweight and obese patients.
